Key result
Machine learning enhances cardiovascular risk stratification, achieving up to ~98% accuracy in image segmentation.
Why the study?
Biological processes in atherosclerosis are complex and heterogeneous, and vast biological datasets require machine learning frameworks to elucidate the intricate molecular and clinical relationships involved in plaque formation and progression.
Answers are grounded in this paper and cite their sources.
Biological processes are incredibly complex-integrating molecular signaling networks involved in multicellular communication and function, thus maintaining homeostasis. Dysfunction of these processes can result in the disruption of homeostasis, leading to the development of several disease processes including atherosclerosis. We have significantly advanced our understanding of bioprocesses in atherosclerosis, and in doing so, we are beginning to appreciate the complexities, intricacies, and heterogeneity atherosclerosi. We are also now better equipped to acquire, store, and process the vast amount of biological data needed to shed light on the biological circuitry involved. Such data can be analyzed within machine learning frameworks to better tease out such complex relationships. Indeed, there has been an increasing number of studies applying machine learning methods for patient risk stratification based on comorbidities, multi-modality image processing, and biomarker discovery pertaining to atherosclerotic plaque formation. Here, we focus on current applications of machine learning to provide insight into atherosclerotic plaque formation and better understand atherosclerotic plaque progression in patients with cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Munger et al. (2021) conducted a review in Atherosclerosis and cardiovascular disease. Machine learning algorithms vs. Traditional statistical and clinical risk assessment methods was evaluated. Machine learning methods improve cardiovascular risk stratification, medical image segmentation (up to 96%–98% accuracy), and biomarker discovery for atherosclerotic plaque progression.
Synapse has enriched 10 related papers. Consider them for comparative context: